Cargando…
A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond
The prevalence of type 2 diabetes is increasing at an astounding rate. Many of the agents used to treat type 2 diabetes have undesirable adverse effects of hypoglycemia and weight gain. Glucagon-like peptide-1 (GLP-1) receptor agonists represent a unique approach to the treatment of diabetes, with b...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Just Medical Media Limited
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509428/ https://www.ncbi.nlm.nih.gov/pubmed/26213556 http://dx.doi.org/10.7573/dic.212283 |